Two Alzheimer’s drugs under-development have failed in their clinical trials. Bapineuzumab and Solanezumab, the two drugs, have been unsuccessful in helping those patients suffering with mild to moderate dementia.
The research, published in the Jan. 23 issue of the New England Journal of Medicine, states that two novel drugs failed in improving the cognitive function of patients.
Smartphones have a new area to explore: They will now take NASA astronaut robots from 2006 tech to the future of space travel. All this is under the Google's experiment Project Tango, which is all set to launch on July 11.
The word given...
An EU-funded research project was launched by Berlin the previous week. This project was...
Sportswear giant Nike has recently announced the launch of a companion Android app for its...
According to a Reuters report, tech giant has recently joined the AllSeen Alliance as a Premier Member. The AllSeen Alliance is considered as the broadest open-source project related to the so-called 'Internet of Things.' It was started by the...
The European Union’s statistics agency, Eurostat, reported on Wednesday that there was stagnancy...
It has been said many times that quantum computing has capability of computing massive amount of...
AT&T has revealed in a recent announcement that it is launching Voice-over-LTE (or VoLTE) and HD Voice support in the US. The combination of the two new features announced by AT&T is expected to bring about an improvement in phone calls...
The Environmental Protection Agency has received as many...
Russian Soyuz-2 rocket will be used to launch UKube-1,...
Blood tests may help predict the onset of Alzheimer's...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).
Subscribe
